Literature DB >> 22581860

Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells.

Lidija Bosnjak1, Peter Sahlström, Dominic Paquin-Proulx, Edwin Leeansyah, Markus Moll, Johan K Sandberg.   

Abstract

Invariant CD1d-restricted NKT (iNKT) cells play important roles in generating protective immune responses against infections. In this study, we have investigated the role of human iNKT cells in HSV-1 infection and their interaction with epidermal keratinocytes. These cells express CD1d and are the primary target of the virus. Keratinocytes loaded with α-galactosyl ceramide (α-GalCer) could stimulate IFN-γ production and CD25 upregulation by iNKT cells. However, both α-GalCer-dependent and cytokine-dependent activation of iNKT cells was impaired after coculture with HSV-1-infected cells. Notably, CD1d downregulation was not observed on infected keratinocytes, which were also found to inhibit TCR-independent iNKT cell activation. Further examination of the cytokine profile of iNKT-keratinocyte cocultures showed inhibition of IFN-γ, IL-5, IL-10, IL-13, and IL-17 secretion but upregulation of IL-4 and TNF-α after the infection. Moreover, cell-to-cell contact between infected keratinocytes and iNKT cells was required for the inhibition of activation, as the cell-free supernatants containing virus did not affect activation. Productive infection of iNKT cells was however not required for the inhibitory effect. After coculture with infected cells, iNKT cells were no longer responsive to further stimulation with α-GalCer-loaded CD1d-expressing cells. We found that exposure to HSV-1-infected cells resulted in impaired TCR signaling downstream of ZAP70. Additionally, infected cells upregulated the expression of the negative T cell regulator, galectin-9; however, blocking experiments indicated that the impairment of iNKT cell responses was independent of galectin-9. Thus, interference with activation of human iNKT cells by HSV-1 may represent a novel immunoevasive strategy used by the virus to avoid immune clearance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581860      PMCID: PMC3370127          DOI: 10.4049/jimmunol.1100218

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.

Authors:  J A Carr; J Rogerson; M J Mulqueen; N A Roberts; R F Booth
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Authors:  D M Koelle; C M Posavad; G R Barnum; M L Johnson; J M Frank; L Corey
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

3.  Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  M Egerton; D R Fitzpatrick; A D Catling; A Kelso
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

4.  Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Authors:  A L Cunningham; R R Turner; A C Miller; M F Para; T C Merigan
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production.

Authors:  F J Dumont; M J Staruch; P Fischer; C DaSilva; R Camacho
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

6.  Role of interferon-gamma in immunity to herpes simplex virus.

Authors:  Z Yu; E Manickan; B T Rouse
Journal:  J Leukoc Biol       Date:  1996-10       Impact factor: 4.962

7.  Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes.

Authors:  M Egerton; D R Fitzpatrick; A Kelso
Journal:  Int Immunol       Date:  1998-02       Impact factor: 4.823

8.  In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production?

Authors:  Z Mikloska; V A Danis; S Adams; A R Lloyd; D L Adrian; A L Cunningham
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

9.  Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.

Authors:  G N Milligan; D I Bernstein
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

10.  Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes.

Authors:  M Ito; M Watanabe; H Kamiya; M Sakurai
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

View more
  10 in total

Review 1.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

2.  A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation.

Authors:  Jianyun Liu; Richard M Gallo; Carol Duffy; Randy R Brutkiewicz
Journal:  Viral Immunol       Date:  2016-06-21       Impact factor: 2.257

3.  A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection.

Authors:  Jianyun Liu; Nicole L Glosson; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 4.  CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections.

Authors:  Brian K Chung; John J Priatel; Rusung Tan
Journal:  Front Immunol       Date:  2015-06-25       Impact factor: 7.561

5.  Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Authors:  Jennifer A Juno; Andrew T Stalker; Jillian Lm Waruk; Julius Oyugi; Makobu Kimani; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  Retrovirology       Date:  2015-02-13       Impact factor: 4.602

6.  Functional paralysis of human natural killer cells by alphaherpesviruses.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Tiffany Ann Russell; David Carl Tscharke; Jarrod John Kennedy; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2019-06-13       Impact factor: 6.823

Review 7.  Ceramide and Related Molecules in Viral Infections.

Authors:  Nadine Beckmann; Katrin Anne Becker
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 8.  Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Authors:  Daniëlle Horst; Ruben J Geerdink; Anna M Gram; Arie J Stoppelenburg; Maaike E Ressing
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

Review 9.  Invariant NKT cells: regulation and function during viral infection.

Authors:  Jennifer A Juno; Yoav Keynan; Keith R Fowke
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

Review 10.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.